Stravencon obtains Marketing Authorisations (MAs) on behalf of its Chinese partners.

MAs are the documents issued by the Regulatory Authority of each EU Member State to permit a company to market a pharmaceutical or biological product within its jurisdiction. MAs are either acquired from current holders or applied for through the regulatory pathways set out by the EU EMEA.